Chemistry:ATC code L04

Short description: Pharmaceutical drug classification

L04A Immunosuppressants

L04AA Selective immunosuppressants

L04AA03 Antilymphocyte immunoglobulin (horse)

L04AA04 Antithymocyte immunoglobulin (rabbit)

L04AA06 Mycophenolic acid

L04AA15 Alefacept

L04AA19 Gusperimus

L04AA22 Abetimus

L04AA24 Abatacept

L04AA28 Belatacept

L04AA32 Apremilast

L04AA40 Cladribine

L04AA41 Imlifidase

L04AA48 Belumosudil

L04AA58 Efgartigimod alfa

L04AB Tumor necrosis factor alpha (TNF-α) inhibitors

L04AB01 Etanercept

L04AB02 Infliximab

L04AB03 Afelimomab

L04AB04 Adalimumab

L04AB05 Certolizumab pegol

L04AB06 Golimumab

L04AB07 Opinercept

L04AC Interleukin inhibitors

L04AC01 Daclizumab

L04AC02 Basiliximab

L04AC03 Anakinra

L04AC04 Rilonacept

L04AC05 Ustekinumab

L04AC07 Tocilizumab

L04AC08 Canakinumab

L04AC09 Briakinumab

L04AC10 Secukinumab

L04AC11 Siltuximab

L04AC12 Brodalumab

L04AC13 Ixekizumab

L04AC14 Sarilumab

L04AC15 Sirukumab

L04AC16 Guselkumab

L04AC17 Tildrakizumab

L04AC18 Risankizumab

L04AC19 Satralizumab

L04AC20 Netakimab

L04AC21 Bimekizumab

L04AC22 Spesolimab

L04AC23 Olokizumab

L04AD Calcineurin inhibitors

L04AD01 Ciclosporin

L04AD02 Tacrolimus

L04AD03 Voclosporin

L04AE Sphingosine 1-phosphate (S1P) receptor modulators

L04AE01 Fingolimod

L04AE02 Ozanimod

L04AE03 Siponimod

L04AE04 Ponesimod

L04AE05 Etrasimod

L04AF Janus-associated kinase (JAK) inhibitors

L04AF01 Tofacitinib

L04AF02 Baricitinib

L04AF03 Upadacitinib

L04AF04 Filgotinib

L04AF05 Itacitinib

L04AF06 Peficitinib

L04AF07 Deucravacitinib

L04AF08 Ritlecitinib

L04AG Monoclonal antibodies

L04AG01 Muromonab-CD3

L04AG02 Efalizumab

L04AG03 Natalizumab

L04AG04 Belimumab

L04AG05 Vedolizumab

L04AG06 Alemtuzumab

L04AG07 Begelomab

L04AG08 Ocrelizumab

L04AG09 Emapalumab

L04AG10 Inebilizumab

L04AG11 Anifrolumab

L04AG12 Ofatumumab

L04AG13 Teprotumumab

L04AG14 Ublituximab

L04AG15 Divozilimab

L04AG16 Rozanolixizumab

L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors

L04AH01 Sirolimus

L04AH02 Everolimus

L04AJ Complement inhibitors

L04AJ01 Eculizumab

L04AJ02 Ravulizumab

L04AJ03 Pegcetacoplan

L04AJ04 Sutimlimab

L04AJ05 Avacopan

L04AJ06 Zilucoplan

L04AJ07 Crovalimab

L04AJ08 Iptacopan

L04AJ09 Danicopan

L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors

L04AK01 Leflunomide

L04AK02 Teriflunomide

L04AX Other immunosuppressants

L04AX01 Azathioprine

L04AX02 Thalidomide

L04AX03 Methotrexate

L04AX04 Lenalidomide

L04AX05 Pirfenidone

L04AX06 Pomalidomide

L04AX07 Dimethyl fumarate

L04AX08 Darvadstrocel

L04AX09 Diroximel fumarate